Skip to main content
Clinical Trials/CTRI/2022/06/043093
CTRI/2022/06/043093
Not yet recruiting
未知

Association of first trimester maternal serum analytes (PAPP-A, BETA HCG, PLGF) with adverse pregnancy outcomes 1 year observational study at KAHERS Dr.Prabhakar Kore hospital and medical research centre

Dr Cheyne Rosetta Estibeiro0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O351- Maternal care for (suspected) chromosomal abnormality in fetus
Sponsor
Dr Cheyne Rosetta Estibeiro
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Dr Cheyne Rosetta Estibeiro

Eligibility Criteria

Inclusion Criteria

  • 1\)All pregnant women between 9 weeks and 13 weeks 6 days POG presenting for the first trimester visit to OPD
  • 2\)Participants who are consenting for enrollment in the study

Exclusion Criteria

  • 1\)women with major ultrasonic or chromosomal abnormalities
  • 2\)k/c/o insulin dependent diabetes mellitus
  • 3\)chronic hypertension
  • 4\)cardiac disorder
  • 5\)renal disorder
  • 6\)multiple gestation

Outcomes

Primary Outcomes

Not specified

Similar Trials